These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Worry about ovarian cancer risk and use of ovarian cancer screening by women at risk for ovarian cancer. Andersen MR; Peacock S; Nelson J; Wilson S; McIntosh M; Drescher C; Urban N Gynecol Oncol; 2002 Apr; 85(1):3-8. PubMed ID: 11925113 [TBL] [Abstract][Full Text] [Related]
3. Proteins' promise--progress and challenges in ovarian cancer proteomics. Koehn H; Oehler MK Menopause Int; 2007 Dec; 13(4):148-53. PubMed ID: 18088525 [TBL] [Abstract][Full Text] [Related]
4. [Mass-screening for ovarian cancer]. Sato S; Higuchi T; Yokoyama Y; Sakamoto T Nihon Rinsho; 2004 Oct; 62 Suppl 10():601-4. PubMed ID: 15535316 [No Abstract] [Full Text] [Related]
5. The importance of test positive predictive value in ovarian cancer screening. Greene MH; Feng Z; Gail MH Clin Cancer Res; 2008 Nov; 14(22):7574; author reply 7577-9. PubMed ID: 18948386 [No Abstract] [Full Text] [Related]
6. Changes in cancer worry associated with participation in ovarian cancer screening. Andersen MR; Drescher CW; Zheng Y; Bowen DJ; Wilson S; Young A; McIntosh M; Mahony BS; Lowe KA; Urban N Psychooncology; 2007 Sep; 16(9):814-20. PubMed ID: 17225260 [TBL] [Abstract][Full Text] [Related]
7. Strategies for ovarian cancer prevention. Dann RB; Kelley JL; Zorn KK Obstet Gynecol Clin North Am; 2007 Dec; 34(4):667-86, viii. PubMed ID: 18061863 [TBL] [Abstract][Full Text] [Related]
9. The medical-surgical nurse's guide to ovarian cancer: part I. Bohnenkamp S; LeBaron V; Yoder LH Medsurg Nurs; 2007 Aug; 16(4):259-66; quiz 267. PubMed ID: 17907699 [No Abstract] [Full Text] [Related]
10. The prostate, lung, colon, and ovarian (PLCO) cancer screening trial: Status and promise. Andriole GL; Reding D; Hayes RB; Prorok PC; Gohagan JK; Urol Oncol; 2004; 22(4):358-61. PubMed ID: 15283897 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic markers for ovarian cancer screening: not ready for routine clinical use. Coates RJ; Kolor K; Stewart SL; Richardson LC Clin Cancer Res; 2008 Nov; 14(22):7575-6; author reply 7577-9. PubMed ID: 18948387 [No Abstract] [Full Text] [Related]
12. [Screening for ovarian cancers: what is the role for marker levels?]. Dargent D Gynecol Obstet Fertil; 2000 Nov; 28(11):855-9. PubMed ID: 11127045 [No Abstract] [Full Text] [Related]
13. Listen for the "whispering disease". Learn the subtle signs and symptoms of ovarian cancer. Martin VR Nurs Manage; 2000 Apr; 31(4):30-1. PubMed ID: 15127636 [No Abstract] [Full Text] [Related]
14. Screening and detection of ovarian cancer. Breedlove G; Busenhart C J Midwifery Womens Health; 2005; 50(1):51-4. PubMed ID: 15637515 [TBL] [Abstract][Full Text] [Related]
15. Knowledge of risk management strategies, and information and risk management preferences of women at increased risk for ovarian cancer. Tiller K; Meiser B; Gould L; Tucker K; Dudding T; Franklin J; Friedlander M; Andrews L Psychooncology; 2005 Apr; 14(4):249-61. PubMed ID: 15386771 [TBL] [Abstract][Full Text] [Related]
18. Patient page #63. Ovarian cancer. What you need to know! J Okla State Med Assoc; 2005 Sep; 98(9):466-7. PubMed ID: 16295981 [No Abstract] [Full Text] [Related]
19. [New advances in screening and treatment of ovarian cancer]. Morice P; Pautier P; Bidart JM Bull Cancer; 2003 Jan; 90(1):53-60. PubMed ID: 12609805 [TBL] [Abstract][Full Text] [Related]
20. Cancer prevention and the American Society of Clinical Oncology. Lippman SM; Levin B; Brenner DE; Gordon GB; Aldige CR; Kramer BS; Garber JE; Hawk E; Ganz PA; Somerfield MR; J Clin Oncol; 2004 Oct; 22(19):3848-51. PubMed ID: 15353541 [No Abstract] [Full Text] [Related] [Next] [New Search]